CTI BioPharma Corp (NASDAQ: CTIC) Receives FDA Clearance Of VONJO For Cytopenic ...

Retrieved on: 2022-03-08 04:34:24

Tags for this article:

Click the tags to see associated articles and topics

CTI BioPharma Corp (NASDAQ: CTIC) Receives FDA Clearance Of VONJO For Cytopenic .... View article details on hiswai:

Excerpt

CTI BioPharma Corp (NASDAQ: CTIC) has announced that the FDA has approved VONJO (pacritinib) for the treatment of individuals with intermediate ...

Article found on: biopharmajournal.com